right-icon

Back to blog

Research Highlights Deep learning networks identify novel ionizable lipids - Echelon Biosciences

Deep learning network identifies novel, functional ionizable lipids

Over the last decade there has been increasing interest in harnessing RNA in novel therapuetic modalities. With the approval of th...

2 minute read
By Cameron Day
November 22

Over the last decade there has been increasing interest in harnessing RNA in novel therapuetic modalities. With the approval of the first siRNA drug in 2018 and the subsequent success of the mRNA vaccines for SARS-CoV-2, the lipid nanoparticle (LNP) delivery systems for these drugs has come into sharper focus. Common LNP formulations contain four types of lipids, with one, the ionizable lipid, having dual packaging and release functions for the RNA cargo. However, the specific chemistry and structure of any single ionizable lipid is not broadly generalizable across applications or to individual cells and tissues. Therefore there is a growing need for a deeper pool of these lipids to choose from as new RNA-based applications are developed.

To date, design of ionizable lipids has relied on generation of libraries via combinatorial chemistry and then high-throughput screening to identify ionizable lipids with unique properties. While these techniques are highly reliable, the time and cost associated with screening such extensive libraries can be prohibitive. These constraints also mean that some lipid components may be excluded from the design stage altogether thus limiting the structural variety of lipids that are screened. The scope of this problem is one that is uniquely suited to be addressed by deep learning algorithms.

Recent work by Li and colleagues at the University of Toronto demonstrate how deep learning tools can be utilized to develop new ionizable lipids. Their platform, AI-Guided Ionizable Lipid Engineering (AGILE), utilizes structural data from libraries of small molecules and lipids which is then refined by experimental data. This parallel training enables comparison between the structures of ionizable lipids and their functional characteristics. They present evidence that their model can predict the effectiveness novel ionizable lipids allowing researchers to design, synthesize, and evaluate ionizable lipids tailored for mRNA delivery across different cell types.

To validate the AGILE platform, novel structures were benchmarked against two well charaterized ionizable lipids, DLin-MC3-DMA and ALC-0315 (Echelon N-1020, N-1282). With this approach, AGILE successfully identified two ionizable lipids, H9 and R6, with high mRNA delivery efficiency for muscle and macrophage cells, respectively. While AGILE is not a generative AI platform, the current data highlight it's potential to rapidly identify structure-activity relationships which could dramatically reduce screening and validation time for new ionizable lipids.

Read the full article here:

AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery

Nature Communications (2024)

0.2

/ 0.3

Related Articles

Stay informed with our informative blog posts.

Research Highlights
Deep learning networks identify novel ionizable lipids - Echelon Biosciences

Deep learning network identifies novel, functional ionizable lipids

Over the last decade there has been increasing interest in harnessing RNA in novel therapuetic modalities. With the approval of th

2 minute read
By Cameron Day
November 22

Research Highlights
hPAC channels are regulated by PI(4,5)P2 to enhance cell survival

PI(4,5)P2 regulates chloride channels during acidosis

Acidic pH is required in some intracellular organelles, but in the extracellular environment it can be highly damaging to cells. E

2 minute read
By Cameron Day
November 1

Research Highlights
Echelon Bioscience - lipid-dependent activation of STING

Lipid-dependent activation of the STING pathway

The cGAS/STING pathway is a critical part of the innate immune system that detects cytosolic DNA and promotes inflammatory respons

2 minute read
By Cameron Day
March 22

Research Highlights
Dissecting microglia to identify new targets in Alzheimer's disease (INPP5D) - Echelon Biosciences

Lipid phosphatase INPP5D emerges as key regulator of inflammasome in microglia

Alzheimer’s disease (AD) has long been characterized by the presence of plaques in neuronal tissue composed primarily of amyloid

3 minute read
By Cameron Day
January 9

Research Highlights
Echelon Biosciences - formation of cellular condensates may permit unique lipid biology

Phase-separated condensates may be microdomains for unique lipid biology

The concept of biological, intracellular phase separation has existed for some time. However, until recently direct evidence for t

2 minute read
By Cameron Day
November 27

Research Highlights
Echelon Biosciences - A phosphatidylinositol kinase could be a new target for autoimmune therapy

A phosphatidylinositol kinase could be a new target for autoimmune therapy

Interleukin-17 (IL-17) is a cytokine produced by a specific type of T cell and is involved in restricting invasive microbes. Despi

3 minute read
By Cameron Day
November 3

0.3

/ 0.3

Get in Touch

If you have any questions or would like to learn more about our services, feel free to reach out to us. We’re here to help!

Contact Echelon
Biosciences
Basket

Your Echelon Basket is empty.